Dapagrav
Dapagliflozin
Type 2 diabetes mellitus; also indicated in heart failure and chronic kidney disease per approved labelling.
Each film-coated tablet contains Dapagliflozin Propanediol equivalent to Dapagliflozin.
Co-former stability maintained through controlled drying end-points and protective film coat.
This information is intended for healthcare professionals and trade partners. The brand name applies to Graviti's own branded generics range in India; in other markets the same formulation is supplied as a generic under our filings or a partner label. Prescribing information, registration status and pack availability vary by market. Medicines should be used only under qualified medical supervision.
Dapagrav — made to the same standard as every Graviti batch.